CELLULAR & MOLECULAR BIOLOGY LETTERS
Scope & Guideline
Advancing the Frontiers of Cellular and Molecular Science
Introduction
Aims and Scopes
- Cancer Biology:
Research on the molecular mechanisms underlying cancer progression, including studies on tumor microenvironments, cancer stem cells, and therapeutic resistance. - Cellular Signaling and Regulation:
Exploration of signaling pathways involved in cellular processes such as proliferation, differentiation, and apoptosis, with implications for disease treatment. - Genomics and Epigenetics:
Investigation of genetic and epigenetic factors influencing cell behavior, including studies on non-coding RNAs, methylation patterns, and gene editing technologies. - Metabolic Disorders:
Research focused on the molecular basis of metabolic diseases, particularly how cellular metabolism affects disease progression and treatment responses. - Stem Cell Biology:
Studies on the mechanisms of stem cell differentiation, regeneration, and their roles in tissue repair and cancer. - Neurobiology and Neurodegenerative Diseases:
Investigations into the cellular and molecular underpinnings of neurological disorders, including studies on neuroinflammation and synaptic plasticity. - Innovative Therapeutics:
Research into novel therapeutic approaches, including the use of stem cells, exosomes, and CRISPR technologies for disease treatment.
Trending and Emerging
- RNA Modifications and Non-coding RNAs:
A surge in research on RNA modifications, particularly N6-methyladenosine (m6A), and the roles of non-coding RNAs in gene regulation and cancer biology is evident. - Targeted and Precision Medicine:
Emerging studies emphasize personalized therapeutic approaches, particularly in cancer treatment, through the use of biomarkers and tailored therapies. - Microbiome Influence on Disease:
Research increasingly explores how the microbiome affects cellular processes and disease outcomes, revealing significant interactions between gut health and systemic diseases. - Autophagy and Cellular Homeostasis:
There is a growing interest in the role of autophagy in maintaining cellular health and its implications for various diseases, including cancer and neurodegeneration. - CRISPR and Gene Editing Technologies:
The application of CRISPR and other gene-editing technologies continues to expand, influencing research in genetic diseases, cancer, and therapeutic innovations. - Cancer Immunotherapy:
Research on the mechanisms of immune evasion by tumors and the development of immunotherapeutic strategies is gaining momentum, reflecting the shift towards harnessing the immune system in cancer treatment. - Metabolic Reprogramming in Disease:
An increasing focus on how metabolic changes in cells contribute to disease progression, particularly in cancer and metabolic disorders, is becoming a prominent theme.
Declining or Waning
- Traditional Pharmacology:
Research that emphasizes conventional drug development and pharmacodynamics has seen a decline, with a shift towards more innovative and targeted therapeutic strategies. - Basic Cellular Mechanisms:
Studies solely focused on fundamental cellular processes without a clear application to disease or therapeutic relevance appear to be less frequent. - In vitro Studies without Translational Relevance:
There seems to be a decrease in in vitro studies that do not connect findings to potential clinical applications or translational research. - Animal Models with Limited Human Relevance:
Research utilizing animal models that do not effectively mimic human disease conditions is becoming less common, as the field emphasizes more relevant translational models.
Similar Journals
CELLULAR SIGNALLING
Illuminating Pathways in Biochemistry and GeneticsCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Leading Insights into Developmental ProcessesSEMINARS IN CELL & DEVELOPMENTAL BIOLOGY is a premier journal published by Academic Press Ltd - Elsevier Science Ltd, focusing on the vital domains of cell and developmental biology. With an impact factor that reflects its rigorous contributions to the field, this journal embodies the highest standards of academic excellence, currently ranking in the Q1 quartile for both Cell Biology and Developmental Biology categories as of 2023. Researchers and practitioners will appreciate its robust Scopus ranking, placing it within the top tiers of developmental biology and cell biology, with percentile ranks of 94th and 90th respectively, showcasing the journal's influential presence in the scientific community. The journal aims to disseminate comprehensive reviews, cutting-edge research articles, and significant advances in the understanding of cellular mechanisms and developmental processes, thereby catering to a diverse audience that includes researchers, scholars, and students dedicated to the life sciences. Given its commitment to open access, SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY promotes widespread dissemination of knowledge, enhancing collaborative research efforts and driving innovation across biological disciplines.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Showcasing Breakthroughs in Cellular PhysiologyCellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.
FEBS Journal
Pioneering Discoveries in Life SciencesFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
TRENDS IN CELL BIOLOGY
Shaping the Future of Cell Biology ResearchTRENDS IN CELL BIOLOGY, published by CELL PRESS, is a premier journal in the field of cell biology, recognized for its high-impact contributions since its inception in 1991. As a distinguished member of the Q1 quartile within its category, the journal holds an impressive Scopus ranking of #8 out of 285, placing it in the 97th percentile of the field, which underscores its reputation for excellence. The journal serves as an essential resource for researchers, professionals, and students who are engaged with groundbreaking advancements in biochemistry, genetics, and molecular biology. Although it is not open access, it provides critical insights into the latest trends, reviews, and advancements in cell biology, making it a crucial tool for anyone committed to understanding the complexities of cellular systems. With a focus on innovative and transformative research, TRENDS IN CELL BIOLOGY continues to shape the discourse in cell biology and enhance the scientific community's knowledge.
Journal of Molecular Cell Biology
Unlocking the secrets of cellular mechanisms.The Journal of Molecular Cell Biology, published by Oxford University Press, is a leading platform for groundbreaking research in the fields of cell biology, genetics, and molecular biology. With an impact factor that places it in the Q1 and Q2 quartiles across key academic categories, this journal has become an essential resource for researchers and professionals committed to advancing our understanding of cellular mechanisms and genetic processes. Since becoming Open Access in 2019, it has enhanced the accessibility of high-quality research, fostering collaboration and knowledge sharing within the scientific community. The journal's Scopus rankings reflect its significant impact in the field, particularly in genetics and molecular biology, ranking within the top percentiles. With a convergence of research spanning from 2009 to 2024, the Journal of Molecular Cell Biology remains at the forefront of innovative discoveries and critical discussions, making it a vital resource for students, academics, and industry experts alike.
DEVELOPMENTAL CELL
Illuminating the Dynamic Landscape of Cell BiologyDEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.
Cell Discovery
Advancing the Frontiers of Cellular ScienceCell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.
CELL BIOLOGY INTERNATIONAL
Exploring the Frontiers of Cellular ScienceCELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.
CYTOTECHNOLOGY
Innovative Insights: Shaping the Future of Bioengineering and Biotechnology.CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.